Page last updated: 2024-11-08

curcudiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

curcudiol: RN given for (S)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID184024
CHEMBL ID504569
SCHEMBL ID24278905
MeSH IDM0424461

Synonyms (16)

Synonym
curcudiol
2-[(1s)-5-hydroxy-1,5-dimethylhexyl]-5-methylphenol
(+)-curcudiol
2-[(1s)-5-hydroxy-1,5-dimethyl-hexyl]-5-methyl-phenol
2-(6-hydroxy-6-methylheptan-2-yl)-5-methylphenol
(1s)-curcudiol
(s)-(+)-curcudiol
CHEMBL504569
109028-15-1
helianane
benzenepentanol, 2-hydroxy-alpha,alpha,epsilon,4-tetramethyl-, (epsilons)-
(+)-helianane
benzenepentanol, 2-hydroxy-alpha,alpha,epsilon,4-tetramethyl-, (s)-
DTXSID40910972
SCHEMBL24278905
benzenepentanol, 2-hydroxy-.alpha.,.alpha.,?,4-tetramethyl-, (?s)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID355801Antioxidant activity against TPA-induced ROS production in human HL60 cells by 2',7'-dichlorodihydrofluorescein diacetate cellular-based assay2003Journal of natural products, May, Volume: 66, Issue:5
Marine natural products as novel antioxidant prototypes.
AID361162Antituberculosis activity against Mycobacterium tuberculosis2002Journal of natural products, Nov, Volume: 65, Issue:11
Microbial and chemical transformation studies of the bioactive marine sesquiterpenes (S)-(+)-curcuphenol and -curcudiol isolated from a deep reef collection of the Jamaican sponge Didiscus oxeata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]